Modern lifestyles have driven a dramatic rise in type 2 diabetes worldwide. Global scientific projections warn that by the end of this decade, the number of people living with diabetes will reach 500 million — a concerning jump from the roughly 400 million cases recorded at the end of the previous decade. One of the most serious consequences of this surge is the growing threat to vision through diabetic retinopathy — a condition increasingly recognized as a major public health challenge.
A Closer Look at Diabetic Retinopathy
Diabetic retinopathy is a disease in which chronically high blood sugar levels cause progressive damage to the delicate blood vessels of the retina — the light-sensitive tissue at the back of the eye. Approximately one in three people with diabetes may develop vision-related complications, and without timely intervention, these can lead to severe, irreversible loss of visual function.
“In its early stages, the condition often gives no warning signs. Patients may notice no changes at all,” explains Dr. Konstantinos G. Fotis, Director of the Posterior Segment Department and Vitreoretinal Surgeon at the 2nd Ophthalmology Clinic of Metropolitan Hospital. “As the disease progresses, symptoms become more apparent: temporary or persistent blurring of vision, floaters (dark spots or strings), difficulty reading — and, in advanced cases, permanent vision damage or blindness. It’s critical to understand that retinal vascular damage can be irreversible. Early diagnosis is therefore the patient’s only true ally.”
Modern Management and the Critical Role of Monitoring
Advances in medical science now offer effective treatments to preserve vision for a large proportion of patients. Today’s ophthalmology toolkit includes specialized laser therapy — which helps stabilize the condition and prevent further leakage from damaged vessels — as well as innovative intravitreal injections. For more advanced cases, new microsurgical techniques allow precise, minimally invasive interventions.
“Diabetes is a serious, multifactorial disease that has taken on pandemic proportions. Over time, it increasingly affects younger age groups — particularly the working-age population aged 40–60. While science has made significant strides in delivering advanced therapies, prevention remains the best approach. Since diabetes affects the entire body systemically, every person with diabetes should undergo an annual comprehensive check-up with their physician — and strictly follow medical guidance,” adds Dr. Fotis.